Actively Recruiting
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Led by Shanghai Jiao Tong University School of Medicine · Updated on 2024-04-17
500
Participants Needed
3
Research Sites
1039 weeks
Total Duration
On this page
Sponsors
S
Shanghai Jiao Tong University School of Medicine
Lead Sponsor
S
Shanghai 10th People's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to determine if the commonly administered chemotherapeutic agents including cisplatin, carboplatin, oxaliplatin, docetaxel and gemcitabine for solid tumors in clinical oncology, either a single format or given as combinations followed by surgery are effective in the treatment of relapsed and refractory non-small cell lung cancer patients.
CONDITIONS
Official Title
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 75 years or younger with histologically proven non-small cell lung cancer
- No severe major organ dysfunction
- WHO performance status of 0 or 1
- No prior cancer chemotherapy
- Clinical Stage IA or higher lung disease without distant metastasis confirmed by pleural CT scan before surgery
You will not qualify if you...
- Age 76 years or older
- Severe major organ dysfunction
- WHO performance status greater than 1
- Prior cancer chemotherapy
- Stage IV lung cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
China-Japan Union Hospital, Jilin University
Changchun, Jilin, China, 130033
Actively Recruiting
2
Shanghai 10th People's Hospital
Shanghai, China, 200072
Actively Recruiting
3
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Shanghai, China, 200433
Actively Recruiting
Research Team
Y
Yu Sun, Ph.D
CONTACT
W
Weijun Ma, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here